A double-blinded randomized controlled trial (10) by the U.S. Veterans Affairs reported that PPC significantly improved alanine aminotransferase (ALT) levels in hepatitis C virus (HCV)-infected patients with alcoholic liver disease. The gene discussed is GPT; the disease is alcoholic liver diseases.